0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mapping functional regions of essential bacterial proteins with dominant-negative protein fragments

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          Peptide fragments derived from protein sequences can inhibit interactions of their parental proteins, providing tools to study protein function in vivo. Here, we employed a massively parallel assay to measure inhibition of Escherichia coli growth by fragments tiling the sequences of 10 of its essential proteins. We leveraged these data to decipher principles of fragment-based inhibition, demonstrating that parental protein concentration drives activity and characterizing how fragment length interplays with activity and specificity. We employed statistical analysis to parse the roles of biophysical properties in fragment-to-fragment variation, finding that the specific characteristics of each fragment largely drive its inhibitory activity. These results advance our understanding of protein interactions in vivo and have implications for the rational design of peptide inhibitors.

          Abstract

          Massively parallel measurements of dominant-negative inhibition by protein fragments have been used to map protein interaction sites and discover peptide inhibitors. However, the underlying principles governing fragment-based inhibition have thus far remained unclear. Here, we adapted a high-throughput inhibitory fragment assay for use in Escherichia coli, applying it to a set of 10 essential proteins. This approach yielded single amino acid resolution maps of inhibitory activity, with peaks localized to functionally important interaction sites, including oligomerization interfaces and folding contacts. Leveraging these data, we performed a systematic analysis to uncover principles of fragment-based inhibition. We determined a robust negative correlation between susceptibility to inhibition and cellular protein concentration, demonstrating that inhibitory fragments likely act primarily by titrating native protein interactions. We also characterized a series of trade-offs related to fragment length, showing that shorter peptides allow higher-resolution mapping but suffer from lower inhibitory activity. We employed an unsupervised statistical analysis to show that the inhibitory activities of protein fragments are largely driven not by generic properties such as charge, hydrophobicity, and secondary structure, but by the more specific characteristics of their bespoke macromolecular interactions. Overall, this work demonstrates fundamental characteristics of inhibitory protein fragment function and provides a foundation for understanding and controlling protein interactions in vivo.

          Related collections

          Most cited references48

          • Record: found
          • Abstract: found
          • Article: not found

          Basic local alignment search tool.

          A new approach to rapid sequence comparison, basic local alignment search tool (BLAST), directly approximates alignments that optimize a measure of local similarity, the maximal segment pair (MSP) score. Recent mathematical results on the stochastic properties of MSP scores allow an analysis of the performance of this method as well as the statistical significance of alignments it generates. The basic algorithm is simple and robust; it can be implemented in a number of ways and applied in a variety of contexts including straightforward DNA and protein sequence database searches, motif searches, gene identification searches, and in the analysis of multiple regions of similarity in long DNA sequences. In addition to its flexibility and tractability to mathematical analysis, BLAST is an order of magnitude faster than existing sequence comparison tools of comparable sensitivity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Highly accurate protein structure prediction with AlphaFold

            Proteins are essential to life, and understanding their structure can facilitate a mechanistic understanding of their function. Through an enormous experimental effort 1 – 4 , the structures of around 100,000 unique proteins have been determined 5 , but this represents a small fraction of the billions of known protein sequences 6 , 7 . Structural coverage is bottlenecked by the months to years of painstaking effort required to determine a single protein structure. Accurate computational approaches are needed to address this gap and to enable large-scale structural bioinformatics. Predicting the three-dimensional structure that a protein will adopt based solely on its amino acid sequence—the structure prediction component of the ‘protein folding problem’ 8 —has been an important open research problem for more than 50 years 9 . Despite recent progress 10 – 14 , existing methods fall far short of atomic accuracy, especially when no homologous structure is available. Here we provide the first computational method that can regularly predict protein structures with atomic accuracy even in cases in which no similar structure is known. We validated an entirely redesigned version of our neural network-based model, AlphaFold, in the challenging 14th Critical Assessment of protein Structure Prediction (CASP14) 15 , demonstrating accuracy competitive with experimental structures in a majority of cases and greatly outperforming other methods. Underpinning the latest version of AlphaFold is a novel machine learning approach that incorporates physical and biological knowledge about protein structure, leveraging multi-sequence alignments, into the design of the deep learning algorithm. AlphaFold predicts protein structures with an accuracy competitive with experimental structures in the majority of cases using a novel deep learning architecture.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              UniProt: the universal protein knowledgebase in 2021

              (2020)
              Abstract The aim of the UniProt Knowledgebase is to provide users with a comprehensive, high-quality and freely accessible set of protein sequences annotated with functional information. In this article, we describe significant updates that we have made over the last two years to the resource. The number of sequences in UniProtKB has risen to approximately 190 million, despite continued work to reduce sequence redundancy at the proteome level. We have adopted new methods of assessing proteome completeness and quality. We continue to extract detailed annotations from the literature to add to reviewed entries and supplement these in unreviewed entries with annotations provided by automated systems such as the newly implemented Association-Rule-Based Annotator (ARBA). We have developed a credit-based publication submission interface to allow the community to contribute publications and annotations to UniProt entries. We describe how UniProtKB responded to the COVID-19 pandemic through expert curation of relevant entries that were rapidly made available to the research community through a dedicated portal. UniProt resources are available under a CC-BY (4.0) license via the web at https://www.uniprot.org/.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc Natl Acad Sci U S A
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                24 June 2022
                28 June 2022
                24 December 2022
                : 119
                : 26
                : e2200124119
                Affiliations
                [1] aDepartment of Genome Sciences, University of Washington , Seattle, WA 98195;
                [2] bDepartment of Medicine, University of Washington , Seattle, WA 98195
                Author notes
                3To whom correspondence may be addressed. Email: fields@ 123456uw.edu .

                Edited by William DeGrado, University of California, San Francisco, CA; received January 4, 2022; accepted May 8, 2022

                Author contributions: A.S. and S.F. designed research; A.S. and A.F. performed research; A.S. analyzed data; and A.S. and S.F. wrote the paper.

                1Present address: Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142.

                2Present address: Program in Molecular and Cellular Biology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington 98195.

                Author information
                https://orcid.org/0000-0002-0333-3199
                https://orcid.org/0000-0001-8006-1724
                https://orcid.org/0000-0001-5504-5925
                Article
                202200124
                10.1073/pnas.2200124119
                9245647
                35749361
                ab94d975-d74e-497a-bb38-4624111da59e
                Copyright © 2022 the Author(s). Published by PNAS.

                This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).

                History
                : 08 May 2022
                Page count
                Pages: 11
                Funding
                Funded by: HHS | National Institutes of Health (NIH) 100000002
                Award ID: F32 GM134557
                Award Recipient : Andrew Savinov Award Recipient : Andres Fernandez Award Recipient : Stanley Fields
                Funded by: HHS | National Institutes of Health (NIH) 100000002
                Award ID: RM1 HG010461
                Award Recipient : Andrew Savinov Award Recipient : Andres Fernandez Award Recipient : Stanley Fields
                Funded by: HHS | National Institutes of Health (NIH) 100000002
                Award ID: P41 GM103533
                Award Recipient : Andrew Savinov Award Recipient : Andres Fernandez Award Recipient : Stanley Fields
                Categories
                423
                Biological Sciences
                Microbiology

                inhibitory peptides,massively parallel measurements,protein interactions,dominant-negative,e. coli

                Comments

                Comment on this article